Literature DB >> 7598644

Comparative studies on the antiallergic effects of kampo medicines used for the therapy of respiratory diseases.

A K Nyunt1, Y Takeuchi, K Yokomuro, Y Miyanaga.   

Abstract

Eight kinds of kampo medicines mainly used for the treatment of asthma and other respiratory diseases, whose comparative effects were still unproven, were selected for comparison of their antiallergic activity in the present study. 1) In an experiment on 48-hr PCA reaction in rats passively sensitized with anti egg albumin IgE antisera, inhibitory effects were observed in those groups orally administered with the tested kampo medicines. Among the drugs tested, TJ-19 showed a potent inhibitory activity as effective as that of tranilast (TL). 2) In the study of extraction method, the effects of kampo drugs varied widely according to the extraction method by which they were prepared. This suggests that the routine methods for preparing these extracts should be reconsidered to achieve the optimal efficacy. 3) In the study of histamine release from rat peritoneal cells stimulated with compound 48/80, TJ-55, TJ-19 and TL exerted a strong inhibition, but TJ-119, TJ-29 and TJ-96 had a weak inhibition. 4) TJ-96, TJ-19 and TL exerted a strong inhibitory effect on LTC, release from rat peritoneal mast cells induced by calcium (Ca) ionophore A23187, but TJ-95, TJ-55 and TJ-119 exerted only a weak inhibition. To sum up of the results, any of these kampo medicines have unique pharmacological action and antiallergic effects. Besides, the method for extraction affects the efficacy of kampo medicine in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598644

Source DB:  PubMed          Journal:  Arerugi        ISSN: 0021-4884


  3 in total

1.  Herbal medicine treatment reduces inflammation in a murine model of cockroach allergen-induced asthma.

Authors:  Jiyoun Kim; Sudha Natarajan; Hyunsu Bae; Sung-Ki Jung; William Cruikshank; Daniel G Remick
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-12       Impact factor: 6.347

2.  Mao-to Prolongs the Survival of and Reduces TNF-alpha Expression in Mice with Viral Myocarditis.

Authors:  Zhu Shijie; Junji Moriya; Jun'ichi Yamakawa; Rui Chen; Takashi Takahashi; Hiroyuki Sumino; Takeshi Nakahashi; Kunimitsu Iwai; Shigeto Morimoto; Nobuo Yamaguchi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-24       Impact factor: 2.629

3.  Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Authors:  Qinglin Zha; Seqi Lin; Chi Zhang; Christopher Chang; Hanrong Xue; Cheng Lu; Miao Jiang; Yan Liu; Zuke Xiao; Weiyou Liu; Yunfei Shang; Jianjian Chen; Minyong Wen; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-03       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.